QIAGEN

Name: QIAGEN
Address: Qiagen Str. 1, Hilden, 40724, DE
Telephone: +492103290
Price range: ££

QIAGEN is the leading provider of sample to insight solutions. Everyone has the right to express their own opinion
• Respecting the rights of others

2.

Links to websites are provided for convenience and do not imply sponsorship, affiliation or endorsement. Guidelines when using our page

We ask that you please adhere to the following guidelines when using our page:

1. Netiquette

Posting and commenting on our page should follow these general communications rules:

• Treating all other users as you would like to be tre

ated by them
• Respecting the opinions of others and not trying to force your opinion on anyone else. Deletion of posts/comments and blocking Facebook accounts

The following actions are examples that are seen as violations of the terms of use. These actions will result in the immediate deletion of posts/comments or, in the case of gross or repeated violations, we will block the user so that he or she is not able to post further content or comments on our page:

• Personal insults or degrading comments of any kind
• Defamatory, anti-constitutional, racist, or pornographic statements or illustrations
• Disparaging comments about institutions, organizations or companies, sexist or racist comments, or hate propaganda
• Any violation of the rights of third parties, in particular copyrights
• Comments that do not relate to the messages under discussion or that are off-topic
• Attacking others or calling for violence of any kind
• Calls to join in demonstrations or rallies of any political orientation
• Offering goods or services, of either a commercial or private nature, or using this page as an advertising space
• Spam, i.e., any form of automatically generated content or repeatedly posting the same comment

3. Privacy policy

We created this page in order to connect and facilitate with interested people an exchange about science, biotechnology, healthcare, molecular diagnostics, and other QIAGEN-related topics. The Privacy Policy covers how we handle personal data, which is submitted to Facebook by clicking the “Like” button on our page. This data is also accessible to QIAGEN. The data we receive from Facebook contains:

• Age demographics
• Place of residence (country and city)
• Gender
• Language
• Activity statistics/rate of all people using our page

Facebook provides this data exclusively in a summarized form. QIAGEN does not receive data on individuals or small user groups. We don’t share the data with third parties. User data is used exclusively to administer our page and to learn more about which topics are of interest to our followers so that we can further improve our page’s offering.

4. Disclaimer

The messages posted in response to our articles reflect the opinions of individual members only. We are not liable for the content of any messages, or for conclusions that may be drawn from such messages. QIAGEN makes no representations or warranties of any kind about the accuracy or completeness of the content.

16/06/2026

The shift from qPCR to digital PCR is accelerating, and gene expression is where it gets really interesting. Learn more 👉 https://tinyurl.com/mrpunddu

We are expanding the QIAcuity digital PCR ecosystem with new gene expression solutions, broader assay content and enhanced workflow standardization to support the growing adoption of dPCR across research and biopharma. Here is what is new:

✅ Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas

✅ Expanded Cell and Gene Therapy offerings and workflow automation capabilities strengthen the QIAcuity digital PCR ecosystem

✅ New software capabilities support standardized analysis and reporting across digital PCR workflows

QIAcuity adoption keeps growing, with more than 3,200 placements and over 1,100 publications worldwide.

15/06/2026

We promised to cut 25 tons of plastic this year. We just counted, and it came in at 35. See all the numbers in our Sustainability Statement 2025 ➡️ https://tinyurl.com/35yx5meh

The report breaks down how we cut emissions, saved plastics and advanced circular design across QIAGEN.

✅ Environment

In 2025, we cut our Scope 1 and 2 emissions by 4% compared to 2024 and exceeded our plastic reduction target.

✅ Social

In 2025, we earned 10 Employer of Choice awards across EMEA, the Americas and APAC. We also certified fair pay practices at six locations covering 65% of our workforce, reinforcing our commitment to transparency and fairness for our people.

✅ Governance

Our responsible sourcing efforts continue to advance. In 2025, 62% of our suppliers (measured by emissions) had sustainable engagement goals in place, and we are targeting 67% by 2027. We also reached 90% completion of cyber security awareness training across the company, strengthening our resilience and data protection.

These results mark another step in our ongoing commitment to responsible growth. We continue to invest in meaningful initiatives, broaden our partnerships and embed sustainability deeper into our operations.

11/06/2026

We’ve been keeping QIAsymphony Connect waiting in the wings long enough. Now it’s ready to grab the spotlight.

Join us on June 23 for a special virtual event – QIAsymphony Connect Takes the Stage: Experiences from Clinical Labs. Hear directly from early access users as they share their experience with our next-gen platform for automated clinical nucleic acid extraction. Register now 👉 https://tinyurl.com/3wr8hf6c

What’s on the agenda?

✅ Hear from Myriad Genetics and the Institute of Pathology and Genetics about their experiences with QIAsymphony Connect in their liquid biopsy workflows

✅ Go behind the scenes with the QIAGEN R&D team to see what it takes to build automation for the realities of modern labs

Curious what all the excitement around QIAsymphony Connect is about? This is your chance to find out.

10/06/2026

For Kimberley Howarth-Munro, our Associate Director, Dx Assay Development, the impact of her work became clear when her father was diagnosed with prostate cancer. The treatment that helped him was linked to a QIAGEN companion diagnostic that Kimberley herself had previously worked on. In that moment, the work our teams do every day took on new meaning: improving lives through science.

Kimberley joined QIAGEN more than thirteen years ago on what was meant to be a six-month maternity cover contract as a scientist. Since then her role has evolved significantly. Today she oversees resource planning for more than 140 colleagues while directly leading a team of 20 with a strong focus on developing people through training, collaboration and shared knowledge.

Her impact goes beyond her role. Kimberley also leads the charity committee at our Manchester site, bringing colleagues together through events that support local causes including Francis House, Manchester Children's Hospital, Coffee4Craig and Cancer Research UK.

As Kimberley puts it, “A strong community doesn’t just happen. You build it, nurture it and make space for people to connect, share and grow together.”

On World Prostate Cancer Day, Kimberley's story is a reminder of the personal impact behind scientific progress. Every advancement in diagnostics has the potential to help patients and families navigate some of life's most challenging moments. Through the dedication of colleagues like Kimberley, we continue working to make improvements in life possible.

09/06/2026

QIAGEN and Parse Biosciences joined forces and we are excited to be at in Budapest this week.

Together, we're showcasing integrated workflows that help researchers uncover the molecular landscape of cancer, from sample preparation and single-cell analysis to NGS and digital PCR.

Thanks to all who joined our symposium on tumor infiltrating gamma delta T-cells with Prof. Domenico Mavilio. We had a great discussion on how transcriptome and repertoire profiling can help us better understand tumor and immune cell biology.

Visitors are enjoying the first European sneak-peek at QIAmini – coming soon for easily accessible DNA and RNA purification.

If you're attending EACR, stop by booth 52 – we'd love to connect and discuss your cancer research projects.

01/06/2026

We are stepping up to support infectious disease research and surveillance efforts for the Bundibugyo ebolavirus outbreak. Learn more 👉 https://tinyurl.com/42jyph3h

As reliable genomic data becomes available, laboratories need flexible tools they can evaluate and slot into their existing workflows.

✅ Two custom-designed research-use-only (RUO) QIAcuity digital PCR assays now available to target Bundibugyo ebolavirus sequences associated with the current outbreak

✅ Assays designed for integration into existing QIAcuity to support research, wastewater surveillance and analytical evaluation by qualified laboratories

✅ Our broader Sample to Insight portfolio includes kits for sample preparation and next-generation sequencing to support outbreak research workflows

Public health preparedness depends on the ability of laboratories to evaluate emerging pathogen targets as reliable genomic information becomes available. Our goal remains clear: no country should be left behind when new threats emerge.

These assays are intended for research use only and are not intended for diagnostic procedures.

26/05/2026

Running a high-throughput clinical lab means striving to deliver results with high sensitivity and high accuracy, which all starts with reliable sample extraction. But what if your extraction process could deliver even more?

Automation has always been central to fast-paced clinical testing labs, who are under immense pressure to deliver results with confidence despite rising sample numbers. More samples mean productivity is stretched and sample traceability becomes more complex. Smart automation that can quickly adapt to changing needs, whether it's input volumes, applications or even sample numbers, is the future.

A new IVD automated sample extraction platform is on the horizon, designed to support clinical testing by combining:

✅High DNA/RNA yields for increased downstream assay sensitivity
✅Fast, efficient workflows that boost productivity
✅Simplified sample tracking and seamless digital integration
✅A future-proof platform built to scale with your lab

One system. Multiple applications. Consistent performance you can trust. Automated sample extraction that always ends on a high note. See what's next ➡️ https://tinyurl.com/msase86x

21/05/2026

We are thrilled to announce the global launch of QIA Agent, our new AI-powered digital assistant, now live on qiagen.com. Try it now 👉 https://tinyurl.com/3nkpzc6m

QIA Agent connects researchers to the scientific guidance, product information and workflow support they need, all through a single conversational interface.

✅ Connects experiment planning, product discovery and workflow support through a single conversational interface

✅ Helps reduce time spent searching across systems and connects customers more quickly to relevant QIAGEN information

✅ Expands our digital ecosystem with AI-driven workflow support embedded directly into the customer experience

With more than 260,000 users already registered on My QIAGEN, QIA Agent builds on an established digital customer base to help researchers move faster from questions to decisions across Sample to Insight workflows.

19/05/2026

We are excited to announce a new collaboration with NVIDIA to advance AI-driven drug discovery. Learn more 👉 https://tinyurl.com/3kwfrc3h

Drug discovery depends on connecting complex biological data across genes, diseases, pathways, compounds and clinical evidence. Together with NVIDIA, we are combining QIAGEN Digital Insights' curated biomedical knowledge bases with the NVIDIA BioNeMo platform to help researchers get from data to discovery decisions faster.

Here's what this collaboration brings to the bench:

✅ Integrate NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights' curated biomedical knowledge bases

✅ Jointly advance how disease mechanisms, therapeutic targets and biomarkers are identified

✅ Explore mechanisms, therapeutic targets and biomarkers with greater speed, context and confidence using a graph-based AI approach

✅ Join initial pilot programs available to select pharmaceutical and biotechnology partners, with broader availability in future stages following validation

13/05/2026

We're excited to share that our newly launched QIAsprint Connect has received the prestigious Red Dot Design Award, marking the fifth time a QIAGEN instrument has earned this global recognition.

✅ QIAsprint Connect delivers high-throughput nucleic acid extraction with up to 192 samples per run, all in a compact benchtop footprint. With built-in decontamination control, validated and customizable protocols accessible via an intuitive touchscreen and digital connectivity for remote run monitoring, it helps labs maximize walk-away efficiency and ease of use.

✅ It also introduces a novel consumables concept that reduces plastic use by up to 50% and packaging volume by 40% compared to standard market consumables, helping labs scale more sustainably without compromising performance.

The Red Dot jury recognized QIAsprint Connect for its user-centric functionality and design, reflecting how modern lab instruments should integrate into increasingly digital, high-throughput environments.

This award reinforces our commitment to solutions that don't just fit on your lab bench but also perform better and elevate the everyday lab experience.

Adresse

Qiagen Str. 1
Hilden
40724

Telefon

+492103290

Webseite

http://www.qiagen.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von QIAGEN erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.